QNCX

Market-moving news on Quince Therapeutics (NASDAQ: QNCX): filings, earnings, deals and other events, from REDFILED.

Quince Therapeutics disclosed a continued listing matter in a filing with the SEC.

QNCX

QUINCE THERAPEUTICS Files 8-K Flagging Listing Rule Issue

The biotech filed an Item 3.01 disclosure with the SEC covering a delisting notice or failure to meet a continued listing standard, dated August 31, 2026.